New research highlights the effectiveness of immunizations in preventing severe COVID-19 outcomes
A research collaboration between Yale New Haven Hospital and Harvard found that states with high vaccination rates were successful in eliminating excess mortality due to COVID-19.Source: Yale Daily News
Omicron more deadly; delayed cancer screening results
The new director of the Yale Cancer Center talks about a disturbing trend. More advanced cancers are being detected because so many people put off screenings during the pandemic. “In 2020, women weren’t getting mammograms, men and women weren’t getting colonoscopies,” explains Dr. Eric Winer. He says aside from missing key screenings for cancer, people also are neglecting other health aspects. “There are many people who when they found an initial problem or developed a symptom just tended to delay coming in,” Winer said.Source: WTNH
Four Yale Researchers Honored at the 2022 Association for Clinical and Translational Science Awards
The collaboration that advanced the discovery of ketamine as a treatment for depression was among four Yale award winners at the Association for Clinical and Translational Science (ACTS) annual meeting held in Chicago from April 20 through 22.
Lower Dose of COVID-19 Drug is Effective — and Allows Treatment for More
Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by researchers at Yale and the University of British Columbia, however, finds that using a lower dose of tocilizumab than has been standard is also effective in treating severe cases, and allows up to twice as many patients to be treated. Lower dosages, they found, are also the cost-effective approach in the context of low supply.Source: Yale News
Yale researchers identify remdesivir-resistant variant of SARS-CoV-2 virus in immunocompromised patient
A team of scientists at the Yale Schools of Medicine and Public Health has identified a remdesivir-resistant variant of SARS-CoV-2, the virus that causes COVID-19, in an immunocompromised patient who was being treated with the widely used antiviral agent.
Long COVID deep dive, Part 2: ‘I hope someone with the power to change something is listening’
On this episode of Next Question with Katie Couric, Katie unpacks the systemic issues that are impeding patients’ care and conveys the urgent needs of the long COVID community to elected officials.Source: Next Question with Katie Couric
Long COVID deep dive, Part 1: ‘You need to grieve the life you thought you were going to live’
On this episode of Next Question with Katie Couric — part 1 of a two-part series — Katie attempts to understand long COVID — what it is, what it can do to the body, who is affected, and how it is upending lives.Source: Next Question with Katie Couric